Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
This study is ongoing, but not recruiting participants.
First Received: September 18, 2007   Last Updated: September 16, 2009   History of Changes
Sponsor: Hoffmann-La Roche
Information provided by: Hoffmann-La Roche
ClinicalTrials.gov Identifier: NCT00531817
  Purpose

This 2 arm study will assess the safety and efficacy, with regard to reduction in signs and symptoms, of tocilizumab versus placebo, both in combination with DMARDs, in patients with moderate to severe active rheumatoid arthritis, with an inadequate response to DMARDs. Patients will be randomized in a ratio of 2:1 to receive either tocilizumab 8mg/kg iv or placebo iv every 4 weeks; all patients will also receive stable antirheumatic therapy including permitted DMARDs. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.


Condition Intervention Phase
Rheumatoid Arthritis
Drug: tocilizumab
Drug: Placebo
Drug: Permitted DMARDs
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Safety/Efficacy Study
Official Title: A Randomized, Double Blind, Parallel Group Study to Evaluate the Effect of Tocilizumab Versus Placebo in Reducing the Signs and Symptoms of Rheumatoid Arthritis in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Resource links provided by NLM:


Further study details as provided by Hoffmann-La Roche:

Primary Outcome Measures:
  • Number and percentage of patients with ACR 50 response [ Time Frame: Week 24 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Number and percentage of patients with ACR 20/50/70, and mean change from baseline in DAS 28, RAPID, SF-12, FACIT-F, MOS sleep scale. [ Time Frame: Week 24 ] [ Designated as safety issue: No ]
  • AEs, laboratory parameters. [ Time Frame: Throughout study ] [ Designated as safety issue: No ]

Estimated Enrollment: 570
Study Start Date: September 2007
Estimated Study Completion Date: June 2009
Arms Assigned Interventions
1: Experimental Drug: tocilizumab
8mg/kg iv every 4 weeks
Drug: Permitted DMARDs
As prescribed
2: Placebo Comparator Drug: Placebo
iv every 4 weeks
Drug: Permitted DMARDs
As prescribed

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adult patients, >=18 years of age;
  • active rheumatoid arthritis of >6 months duration;
  • receiving permitted DMARDs each at a stable dose for at least 7 weeks prior to baseline.

Exclusion Criteria:

  • rheumatic autoimmune disease or inflammatory joint disease other than rheumatoid arthritis;
  • major surgery within 8 weeks prior to screening or planned within 6 months following randomization;
  • unsuccessful treatment with a biologic agent, including an anti-TNF agent;
  • previous treatment with tocilizumab.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00531817

  Hide Study Locations
Locations
United States, Alabama
BIRMINGHAM, Alabama, United States, 35215
BIRMINGHAM, Alabama, United States, 35294-7201
BIRMINGHAM, Alabama, United States, 35205
MONTGOMERY, Alabama, United States, 36111
United States, Arizona
SCOTTSDALE, Arizona, United States, 85251
SCOTTSDALE, Arizona, United States, 85258
PARADISE VALLEY, Arizona, United States, 85253
PEORIA, Arizona, United States, 85381
LAKE HAVASU CITY, Arizona, United States, 86403
SCOTTSDALE, Arizona, United States, 85258
United States, Arkansas
JONESBORO, Arkansas, United States, 72401
United States, California
SANTA MONICA, California, United States, 90404
SANTA MARIA, California, United States, 93454
VAN NUYS, California, United States, 91405
LA JOLLA, California, United States, 92037
BEVERLY HILLS, California, United States, 90211
LONG BEACH, California, United States, 90815
PASADENA, California, United States, 91107
WHITTIER, California, United States, 90606
ESCONDIDO, California, United States, 92025
UPLAND, California, United States, 91786
LOS ANGELES, California, United States, 90095
WALNUT CREEK, California, United States, 94598
United States, Colorado
AURORA, Colorado, United States, 80045
COLORADO SPRINGS, Colorado, United States, 80910
United States, Connecticut
TRUMBULL, Connecticut, United States, 06611
United States, District of Columbia
WASHINGTON, District of Columbia, United States, 20006
United States, Florida
ORLANDO, Florida, United States, 32804
TAMARAC, Florida, United States, 33321
PLANTATION, Florida, United States, 33317
DUNEDIN, Florida, United States, 34698
OCALA, Florida, United States, 34474
ORANGE PARK, Florida, United States, 32073
SARASOTA, Florida, United States, 34239
FORT LAUDERDALE, Florida, United States, 33334
MIAMI, Florida, United States, 33133
TAMPA, Florida, United States, 33609
LAKE MARY, Florida, United States, 32746
MELBOURNE, Florida, United States, 32901
PALM HARBOR, Florida, United States, 34684
United States, Georgia
FORT VALLEY, Georgia, United States, 31030
BLUE RIDGE, Georgia, United States, 30513
ATLANTA, Georgia, United States, 30342
TIFTON, Georgia, United States, 311794
United States, Idaho
BOISE, Idaho, United States, 83702
NAMPA, Idaho, United States, 83687
IDAHO FALLS, Idaho, United States, 83404
United States, Illinois
SPRINGFIELD, Illinois, United States, 62704
DOWNERS GROVE, Illinois, United States, 60515
United States, Indiana
EVANSVILLE, Indiana, United States, 47714
MUNSTER, Indiana, United States, 46321
SOUTH BEND, Indiana, United States, 46601
United States, Kansas
LEAWOOD, Kansas, United States, 66209
United States, Kentucky
LEXINGTON, Kentucky, United States, 40515
BOWLING GREEN, Kentucky, United States, 42102
United States, Louisiana
MONROE, Louisiana, United States, 71203
NEW ORLEANS, Louisiana, United States, 70112
BATON ROUGE, Louisiana, United States, 70810
BATON ROUGE, Louisiana, United States, 70808
United States, Maryland
WHEATON, Maryland, United States, 20902
United States, Massachusetts
MANSFIELD, Massachusetts, United States, 02048
WORCESTER, Massachusetts, United States, 01605
WORCESTER, Massachusetts, United States, 01610
United States, Michigan
KALAMAZOO, Michigan, United States, 49009
ST CLAIR SHORES, Michigan, United States, 48080
United States, Minnesota
EAGAN, Minnesota, United States, 55121
United States, Mississippi
FLOWOOD, Mississippi, United States, 39232
TUPELO, Mississippi, United States, 38802
United States, Missouri
ST LOUIS, Missouri, United States, 63141
FLORISSANT, Missouri, United States, 63031
United States, Montana
BILLINGS, Montana, United States, 59101
MISSOULA, Montana, United States, 59802
KALISPELL, Montana, United States, 59901
United States, Nebraska
GRAND ISLAND, Nebraska, United States, 68803
United States, Nevada
LAS VEGAS, Nevada, United States, 89106
LAS VEGAS, Nevada, United States, 89128
RENO, Nevada, United States, 89502
United States, New Hampshire
DOVER, New Hampshire, United States, 03820
United States, New Jersey
FREEHOLD, New Jersey, United States, 07728
NEW BRUNSWICK, New Jersey, United States, 08903
TEANECK, New Jersey, United States, 07666
PASSAIC, New Jersey, United States, 07055
United States, New York
NEW YORK, New York, United States, 10003
ORCHARD PARK, New York, United States, 14127
NEW YORK, New York, United States, 10029
SMITHTOWN, New York, United States, 11787
BRONX, New York, United States, 10451
MINEOLA, New York, United States, 11501
United States, North Carolina
HICKORY, North Carolina, United States, 28601
ROCK HILL, North Carolina, United States, 29732
DURHAM, North Carolina, United States, 27704
GREENVILLE, North Carolina, United States, 27834
CHARLOTTE, North Carolina, United States, 28210
BELMONT, North Carolina, United States, 28012
CHARLOTTE, North Carolina, United States, 28209
GREENSBORO, North Carolina, United States, 27408
United States, Ohio
ZANESVILLE, Ohio, United States, 43701
AKRON, Ohio, United States, 44333
MAYFIELD, Ohio, United States, 44143
BEECHWOOD, Ohio, United States, 44122
PERRYBURG, Ohio, United States, 43551
MIDDLEBURG HEIGHTS, Ohio, United States, 44130
United States, Oklahoma
OKLAHOMA CITY, Oklahoma, United States, 73104
OKLAHOMA CITY, Oklahoma, United States, 73103
NORMAN, Oklahoma, United States, 73069
United States, Oregon
LAKE OSWEGO, Oregon, United States, 97035
PORTLAND, Oregon, United States, 97239
SALEM, Oregon, United States, 97302
United States, Pennsylvania
PHILADELPHIA, Pennsylvania, United States, 19152
BETHLEHEM, Pennsylvania, United States, 10817
PITTSBURGH, Pennsylvania, United States, 15261
PHILADELPHIA, Pennsylvania, United States, 19102
WEXFORD, Pennsylvania, United States, 15090
United States, South Carolina
CHARLESTON, South Carolina, United States, 29407
COLUMBIA, South Carolina, United States, 29204
FLORENCE, South Carolina, United States, 29506
GREENVILLE, South Carolina, United States, 29601
MYRTLE BEACH, South Carolina, United States, 29572
United States, South Dakota
RAPID CITY, South Dakota, United States, 57702
SIOUX FALLS, South Dakota, United States, 57105
WATERTOWN, South Dakota, United States, 57201
RAPID CITY, South Dakota, United States, 57701
United States, Tennessee
MEMPHIS, Tennessee, United States, 38119
JACKSON, Tennessee, United States, 38305
KNOXVILLE, Tennessee, United States, 37909
CROSSVILLE, Tennessee, United States, 38555
HENDERSONVILLE, Tennessee, United States, 37073
NASHVILLE, Tennessee, United States, 37203
United States, Texas
HOUSTON, Texas, United States, 77074
CARROLLTON, Texas, United States, 75007
BELLAIRE, Texas, United States, 77401
DALLAS, Texas, United States, 75231
SAN ANTONIO, Texas, United States, 78217
HOUSTON, Texas, United States, 77034
WACO, Texas, United States, 76708
HOUSTON, Texas, United States, 77004
TEMPLE, Texas, United States, 76508
FORT WORTH, Texas, United States, 76107
SAN ANTONIO, Texas, United States, 78229
AMARILLO, Texas, United States, 79106
MESQUITE, Texas, United States, 75150
AMARILLO, Texas, United States, 79124
SAN ANTONIO, Texas, United States, 78258
HOUSTON, Texas, United States, 77090
United States, Utah
SALT LAKE CITY, Utah, United States, 84132
United States, Vermont
BURLINGTON, Vermont, United States, 05401
United States, Virginia
RESTON, Virginia, United States, 22102
SALEM, Virginia, United States, 24153
BURKE, Virginia, United States, 22015
United States, Washington
SPOKANE, Washington, United States, 99204-2336
SEATTLE, Washington, United States, 98133
SEATTLE, Washington, United States, 98195
United States, West Virginia
BECKLEY, West Virginia, United States, 25801
CLARKSBURG, West Virginia, United States, 26301
United States, Wisconsin
WAUSAU, Wisconsin, United States, 54401
ONALASKA, Wisconsin, United States, 54605
MILWAUKEE, Wisconsin, United States, 53209
Puerto Rico
SAN JUAN, Puerto Rico, 00918
Sponsors and Collaborators
Hoffmann-La Roche
Investigators
Study Director: Clinical Trials Hoffmann-La Roche, +1 973 235 5000
  More Information

No publications provided

Responsible Party: Hoffmann-La Roche ( Clinical Trials, Study Director )
Study ID Numbers: ML21136
Study First Received: September 18, 2007
Last Updated: September 16, 2009
ClinicalTrials.gov Identifier: NCT00531817     History of Changes
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Autoimmune Diseases
Immune System Diseases
Musculoskeletal Diseases
Therapeutic Uses
Joint Diseases
Arthritis
Connective Tissue Diseases
Arthritis, Rheumatoid
Rheumatic Diseases
Antirheumatic Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on November 30, 2009